LifeStance Health Announces $45 Million Secondary Offering and $2 Million Share Repurchase
LifeStance Health (LFST) announced that existing stockholders intend to sell 45 million common shares through a secondary public offering. The company clarified that it is not issuing new shares as part of this transaction and will not receive any proceeds from the sale. In a simultaneous move, LifeStance Health disclosed plans for a $2 million share repurchase program. This dual announcement highlights a significant liquidity event driven by existing shareholders while attempting to provide some level of capital return through the buyback.
Tickers: $LFST
Topics: equity dilution secondary offering stock sale
Read the full article at Seeking Alpha
Part of the story Hagerty Announces Pricing of Upsized 10 Million Share Secondary Offering (4 articles)